Gentle Bio-Sciences Private Limited
Gentle Bio-Sciences Private Limited is a Private Company limited by Shares company incorporated in 2013 and based in Telangana, India. It was founded by Meka. Gentle Bio-Sciences Private Limited operates in Pharmaceuticals & Chemicals (NIC 24100) with authorized capital of ₹50.00 L and paid-up capital of ₹50.00 L. RegisterKaro's Compliance Health Score for the company is 35/100 (grade F), reflecting a weak compliance posture.
GENTLE BIO-SCIENCES PRIVATE LIMITED is the legal entity of Gentle Bio-Sciences.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Gentle Bio-Sciences Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 27 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +8d | filed |
| MGT-7 | FY2022-23 | 26 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Gentle Bio-Sciences Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 572049480 | Axis Bank Ltd(Bank) | ₹7.42 Cr | 19 Sep 2019 | Satisfied |
| 627654407 | Kotak Mahindra Bank Ltd(Bank) | ₹16.42 Cr | 27 Jan 2022 | Open |
| 146504859 | ICICI Bank Ltd(Bank) | ₹22.92 Cr | 27 Jan 2020 | Satisfied |
| 363342140 | State Bank of India(Bank) | ₹12.22 Cr | 04 Jul 2022 | Open |
| 191528213 | State Bank of India(Bank) | ₹20.91 Cr | 19 Sep 2022 | Open |
Charge IDs, lenders & amounts for Gentle Bio-Sciences Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹26.60 Cr | ₹51.26 L | ₹17.39 Cr | ₹43.33 Cr | 28 |
| FY2023-24 | ₹23.85 Cr | ₹77.31 L | ₹10.80 Cr | ₹27.20 Cr | 161 |
| FY2022-23 | ₹22.90 Cr | ₹-3.9K | ₹16.04 Cr | ₹26.88 Cr | 300 |
| FY2021-22 | ₹19.22 Cr | ₹65.11 L | ₹18.83 Cr | ₹29.28 Cr | 197 |
Audited financials & ratios for Gentle Bio-Sciences Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹26.60 Cr | ₹23.85 Cr | ₹22.90 Cr | ₹19.22 Cr |
| Other income | ₹76.43 L | ₹44.90 L | ₹55.42 L | ₹49.52 L |
| Total income | ₹27.37 Cr | ₹24.30 Cr | ₹23.45 Cr | ₹19.72 Cr |
| Total expenses | ₹26.71 Cr | ₹23.31 Cr | ₹23.45 Cr | ₹18.88 Cr |
| Profit before tax | ₹66.64 L | ₹1.01 Cr | ₹-5.1K | ₹84.64 L |
| Profit / (Loss) after tax | ₹51.26 L | ₹77.31 L | ₹-3.9K | ₹65.11 L |
| Balance sheet | ||||
| Equity / Net worth | ₹17.39 Cr | ₹10.80 Cr | ₹16.04 Cr | ₹18.83 Cr |
| Borrowings | ₹13.38 Cr | ₹4.06 Cr | ₹5.30 Cr | ₹2.30 Cr |
| Current liabilities | ₹10.90 Cr | ₹5.41 Cr | ₹5.77 Cr | ₹5.86 Cr |
| Total liabilities | ₹25.94 Cr | ₹16.40 Cr | ₹10.84 Cr | ₹10.46 Cr |
| Current assets | ₹20.88 Cr | ₹14.29 Cr | ₹12.32 Cr | ₹14.23 Cr |
| Cash & equivalents | ₹4.33 Cr | ₹5.10 Cr | ₹3.34 Cr | ₹4.82 Cr |
| Total assets | ₹43.33 Cr | ₹27.20 Cr | ₹26.88 Cr | ₹29.28 Cr |
| Employees | 28 | 161 | 300 | 197 |
Audited financials & ratios for Gentle Bio-Sciences Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹26.60 Cr | +2.0% | +21.7% | +16.5% |
| Profit after Tax | ₹51.26 L | -11.3% | +18.1% | +10.6% |
| Net Worth | ₹17.39 Cr | +24.4% | +4.8% | +2.2% |
| Employees | 28 | +0.5% | +7.0% | +2.1% |
Audited financials & ratios for Gentle Bio-Sciences Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹26.60 Cr | ₹51.26 L | +1.93% | +2.31% | +2.95% | +1.18% | 0.77 | ₹95.02 L |
| FY2023-24 | ₹23.85 Cr | ₹77.31 L | +3.24% | +16.53% | +7.16% | +2.84% | 0.38 | ₹14.81 L |
| FY2022-23 | ₹22.90 Cr | ₹-3.9K | -0.00% | +32.84% | -0.00% | -0.00% | 0.33 | ₹7.63 L |
| FY2021-22 | ₹19.22 Cr | ₹65.11 L | +3.39% | -0.88% | +3.46% | +2.22% | 0.12 | ₹9.76 L |
Audited financials & ratios for Gentle Bio-Sciences Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 2,76,29,724 | 67.03% |
| Institutional Investors | 1 | 47,11,473 | 11.43% |
| Public & Others | 27 | 88,77,082 | 21.54% |
Promoter, institutional & public holding for Gentle Bio-Sciences Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
216 peersEvents & timeline
4External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.